The possibility of catastrophic military or civilian cyanide exposure as a result of a terrorist attack or an industrial accident, is a major challenge for our defense agencies and healthcare infrastructure (1-3) New, effective countermeasures are urgently required. In addition, there is a clear need for a platform capable of moving rapidly from the identification of novel threats through animal modeling to efficient countermeasure discovery. We propose to create an integrated pipeline for the discovery and development of novel candidate countermeasures for cyanide toxicity through the process of therapeutic development toward regulatory approval. We have developed a zebrafish model in which exposure to cyanide causes stereotypical toxicities including bradycardia, neuronal necrosis, and death. Traditional cyanide antidotes are pooriy suited to mass-casualty exposures, but offered key benchmarks for our validation of the zebrafish as an animal model for chemical countermeasure development. In prior work, funded through the NIH CounterACT Program, we have developed and validated a zebrafish model of cyanide toxicity, adapted this model for high-throughput screening, and in 'proof of concept'studies have performed a screen for compounds that reproduclbly rescue zebrafish from lethal cyanide exposure. In this screen (to date of >35,000 compounds), we were able to identify 26 small molecules that rescue cyanide toxicity at concentrations <1uM. These compounds are now moving to Project 2 in order to identify and prioritize optimized lead compounds for subsequent development as outlined in this integrated U54 Center. Optimized leads will in turn be moved to Project 3 where they will be tested in validated murine and rabbit models. We propose to continue our efforts to furnish novel countermeasure classes, through ongoing studies of compounds already identified, the development of refined zebrafish models for specific vulnerable populations, the continued screening of diverse chemical libraries to identify novel hits and the development of scalable strategies for the prioritization of large numbers of emerging hits. In principle, the approach we have outlined is potentially generalizable for any chemical threat whose toxic effects can be modeled in the zebrafish.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54NS079201-03
Application #
8730724
Study Section
Special Emphasis Panel (ZRG1-MDCN-J)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
3
Fiscal Year
2014
Total Cost
$227,222
Indirect Cost
$108,808
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Lee, Jangwoen; Kim, Jae G; Mahon, Sari B et al. (2014) Noninvasive optical cytochrome c oxidase redox state measurements using diffuse optical spectroscopy. J Biomed Opt 19:055001
Buys, Emmanuel; Sips, Patrick (2014) New insights into the role of soluble guanylate cyclase in blood pressure regulation. Curr Opin Nephrol Hypertens 23:135-42
Jackson, Randy; Oda, Robert P; Bhandari, Raj K et al. (2014) Development of a fluorescence-based sensor for rapid diagnosis of cyanide exposure. Anal Chem 86:1845-52
Asnani, Aarti; Peterson, Randall T (2014) The zebrafish as a tool to identify novel therapies for human cardiovascular disease. Dis Model Mech 7:763-7
Peterson, Randall T; Macrae, Calum A (2013) Changing the Scale and Efficiency of Chemical Warfare Countermeasure Discovery Using the Zebrafish. Drug Discov Today Dis Models 10: